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Etiology of Placental Plasmodium 
falciparum Malaria in African Women
Michael F. Ofori,1 Helena Lamptey,1 Emmanuel K. Dickson,1 Eric Kyei-Baafour,1 and 
Lars Hviid2,3
1Noguchi Memorial Institute for Medical Research, University of Ghana, Legon; and 
2Center for Medical Parasitology at Department of Immunology and Microbiology, 
Faculty of Health and Medical Sciences, University of Copenhagen, and 3Department 
of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), 
Copenhagen, Denmark
Plasmodium falciparum parasites causing placental malaria 
express the VAR2CSA type of the clonally variant antigen fam-
ily erythrocyte membrane protein 1 (PfEMP1). This enables 
evasion of preexisting immunity and results in placental accu-
mulation of infected erythrocytes. We present data on seasonal 
variation in levels of VAR2CSA-specific immunoglobulin 
G (IgG) and IgG specific for a placental malaria–unrelated 
PfEMP1 protein among Ghanaian women at their first ante-
natal visit. Our results indicate that placental malaria does not 
require recent exposure to infected mosquitoes, in contrast 
to malaria in general. This has implications for the impact of 
insecticide-treated bed nets on placental malaria incidence and 
for antenatal care in woman with preexisting immunity.
Keywords. IgG; PfEMP1; placental malaria; Plasmodium 
falciparum; VAR2CSA.
 
People living in areas with stable transmission of Plasmodium fal-
ciparum acquire substantial immunity to malaria during child-
hood [1]. This protection is largely mediated by immunoglobulin 
G (IgG) antibodies targeting the asexual blood-stage parasites, 
which are responsible for all the clinical symptoms of malaria 
[2]. IgG targeting P. falciparum antigens on the infected erythro-
cyte surface, in particular members of the clonally variant anti-
gen family erythrocyte membrane protein 1 (PfEMP1), appear 
to be of particular importance [3]. PfEMP1 mediates adhesion 
of mature infected erythrocytes to receptors in the vasculature of 
the infected individual. This tissue sequestration facilitates para-
site evasion of phagocytic destruction of infected erythrocytes in 
the spleen. However, it can also lead to severe disease precipitated 
by inflammation, circulatory disturbances, and high parasite 
loads. PfEMP1-specific IgG is thought to be protective by inter-
fering with infected erythrocyte sequestration and by opsonizing 
infected erythrocytes for improved phagocytosis.
Although P.  falciparum parasites have evolved to subvert 
and delay acquisition of immunity by switching among the 
approximately 60 different PfEMP1 proteins encoded in the 
parasite genome [3], girls living in stable-transmission areas 
have acquired substantial protection from malaria (apart 
from placental infection) well before they reach childbearing 
age. Clinical disease episodes are rare by then, but carriage of 
low-density parasitemia, suppressed by the immune response 
to densities often too low to be detected by rapid diagnostic 
tests or standard examination of blood films, remains com-
mon. This notwithstanding, pregnancy is accompanied by a 
sudden reappearance of susceptibility to malaria, particularly 
among primigravidae. It is now well established that this is 
due to parasites expressing a particular type of PfEMP1. It 
is called VAR2CSA, and it enables sequestration of infected 
erythrocytes in the placenta by binding to an adhesion recep-
tor (oncofetal chondroitin sulfate) available there but not 
elsewhere in the body. Expression of VAR2CSA is therefore 
incompatible with parasite survival in a nonpregnant per-
son. Because VAR2CSA is not only functionally distinct 
but also antigenically distinct from all other PfEMP1 types, 
PfEMP1-specific protective immunity acquired prior to the 
first pregnancy does not protect against infected erythro-
cytes expressing VAR2CSA on their surface. However, once 
the immune system is exposed to VAR2CSA during the first 
placental infection, protective immunity to this antigen type 
develops. Placental malaria is therefore mainly a problem 
during the first few pregnancies. Once acquired, protection 
is maintained between pregnancies by specific memory B 
cells, rather than by VAR2CSA-specific IgG, which normally 
declines to relatively low levels shortly after delivery. This low 
durability of the specific IgG response once the antigen is gone 
is not restricted to VAR2CSA. It is rather the rule for most 
PfEMP1-specific IgG responses and, indeed, for IgG responses 
to many other malaria antigens, as well. With these facts in 
mind, we assessed the relative importance in the etiology of 
placental malaria of infections acquired from mosquitoes 
during pregnancy versus subclinical parasitemia established 
before conception.
METHODS
Study Site and Participants
The study was conducted in the town of Asutsuare, Ghana, 
located about 85 km northeast of Accra. P.  falciparum 
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transmission intensity in this area is seasonally variable, peak-
ing during and immediately after the rainy season [4]. Pregnant 
women, who consented to participate in the study after receiv-
ing oral and written information about its aims at their first 
or second antenatal visit, were recruited consecutively from 
July 2006 to September 2008. Women with any form of preg-
nancy complication were excluded from participation. Data 
regarding age, gestational age, pregnancy history, number of 
remembered previous malaria episodes, clinical data (tempera-
ture, hemoglobin level, blood type, and parasitemia level), and 
a venous anticoagulated (via ethylenediaminetetraacetic acid) 
blood sample (4 mL) were collected from all participants. Some 
plasma samples were inadvertently lost during storage, before 
antibody analysis. Plasma samples from 30 healthy men and 30 
nonpregnant women from the same community were included 
for comparison, and 10 Danish healthy adults without previous 
exposure to P. falciparum were included as negative controls.
Ethics Statement
This study was reviewed and approved by the ethics committee of 
the Noguchi Memorial Institute for Medical Research, University 
of Ghana (permission no. NMIMR-IRB CPN 014/05/-06).
P. falciparum–Specific Plasma Antibody Levels
The plasma levels of IgG antibodies to 2 recombinant PfEMP1 
proteins were measured by enzyme-linked immunosorbent 
assay as described in detail previously [5]. One protein (FV2) 
represented the full-length ectodomain of the VAR2CSA-type 
antigen IT4VAR04. The other protein (FV6) represented the full-
length ectodomain of another PfEMP1 protein (HB3VAR06), 
which is a commonly recognized PfEMP1 antigen that is not 
associated with placental malaria.
Statistical Analysis
Monthly variation (January–December) in rainfall was analyzed 
by 1-way analysis of variance (test statistic: F). The difference 
in antibody levels in women with and without parasitemia was 
analyzed by the Mann-Whitney test (T). Intergroup differences 
(men, pregnant women, and nonpregnant women; and women 
with fetuses of different gestational ages) were evaluated by 
Kruskal-Wallis 1-way analysis of variance on ranks (H), followed 
by the Dunn post hoc test, to isolate statistically significant pair-
wise differences. The association between FV2-specific and FV6-
specific IgG responses was evaluated by Spearman rank-order 
correlation analysis (rs). Associations between antibody levels 
and donor parity were evaluated by the Cuzik test for trend (z). 
P values <.05 were considered statistically significant.
RESULTS
Baseline Characteristics of the Study Participants and Study Site
A total of 807 pregnant women were recruited into the 
study. Recruitment was fairly even over the study period 
(Supplementary Figure  1). Samples from 644 women were 
available for antibody measurements. The characteristics of 
the latter women are summarized in Table 1. The temporal dis-
tribution (by calendar month) of recruitment was similar for 
women with and those without detectable peripheral parasite-
mia (P(T) > .15).
As proxy marker for seasonal variation in P.  falciparum 
transmission intensity in our study area at the time the study 
was conducted, we collected and analyzed monthly rainfall 
data during 2006–2008 from the meteorological records of the 
nearby town of Akuse. The data supported our assumption of 
marked seasonal variation, as significant overall and annual 
seasonal variations in rainfall were evident during the study 
period (P(F) < .001), with peaks in April–May, during the long 
rainy season, and in September, during the short rainy season 
(Supplementary Figure 2).
Plasma Levels of PfEMP1-Specific IgG Among Study Participants
Plasma levels of FV2-specific (Figure  1A) and FV6-specific 
IgG (Figure 1B) differed significantly among the study groups 
(P(H) < .001). Post hoc analysis (by the Dunn test) showed that 
the pregnant women had significantly higher plasma levels of 
FV2- and FV6-specific IgG than the men and the nonpregnant 
women from the same area (P < .05). In contrast, the levels did 
Table 1. Characteristics of Study Participants
Parameter Value
Age, y 25 (20–30)
Parity (n = 634) 2 (1–3)
 0 175
 1 129
 2 119
 >2 211
First antenatal visit
 Evaluated 631
 Yes 580
 No 51
Self-reported prophylaxis
 Evaluated 627
 Yes 245
 No 382
Gestational age, mo (n = 632)a 5 (4–6)
Peripheral parasitemia detected
 Evaluated 644
 Yes 104b
 No 540
Axillary temperature, °C (n = 622) 36.9 (36.5–37.1)
Hemoglobin level, g/L (n = 632) 11.0 (9.9–11.8)
Hemoglobin genotype AS
 Evaluated 633
 Yes 60
 No 573
Data are median value (interquartile range) or no. of participants.
aBased on time since reported last menstruation.
bRange, 80–21 000 asexual parasites/µL.
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not differ significantly between men and nonpregnant women 
for either antigen. Whereas about 40% of the men and non-
pregnant women had FV6-specific IgG levels above the cutoff, 
only about 15% had levels of FV2-specific IgG above the nega-
tive cutoff. There was a moderate positive correlation between 
FV2-specific and FV6-specific IgG plasma levels (P < .0001 and 
rs = .60; n = 634).
Levels of FV2-specific IgG depended significantly and pos-
itively on parity (P(z)  <  .0001; Figure  1C) but did not depend 
significantly on either gestational age at recruitment (P(H) = .7) 
or calendar month of recruitment (P(H)  =  .1). In contrast, 
FV6-specific IgG levels tended to decrease with increasing par-
ity (P(z) = .01; Figure 1D), did not vary with gestational age at 
recruitment (P(H) = .06), but showed marked variation with cal-
endar month of recruitment (P(H) < .001). Essentially identical 
results were obtained when these analyses were restricted to 
primigravidae. Median levels of FV2-specific and FV6-specific 
IgG were lower in women with self-reported prophylaxis (3.78 
and 4.04, respectively) than in women who reported no use of 
prophylaxis (3.91 and 4.22, respectively). The difference was 
highly significant for FV6-specific IgG (P(T) < .001) and border-
line significant for FV2-specific IgG (P(T) = .05).
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Figure 1.  Plasma levels of Plasmodium falciparum family erythrocyte membrane protein 1 (PfEMP1)–specific immunoglobulin G (IgG). A, Levels of FV2-specific IgG in 
plasma from Ghanaian pregnant women, nonpregnant women, and men. Median values (center lines), interquartile ranges (boxes), interdecile ranges (bars), and outliers 
(points) are shown. The number of donors in each group is indicated along the bottom of the panel. Statistically significant differences (P < .05) are indicated by horizontal 
bars along the top of the panel. B, Levels of FV6-specific IgG in plasma from Ghanaian pregnant women, nonpregnant women, and men. Measures of central tendency and 
dispersion are as described in panel A. C, Relationship between plasma levels of FV2-specific IgG and parity among pregnant women. D, Relationship between plasma levels 
of FV6-specific IgG and parity among pregnant women. The cutoff for positivity (calculated as the mean level [plus 2 standard deviations] measured in 10 nonexposed Danish 
control donors) is indicated by gray shading in all panels.
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DISCUSSION
The incidence of clinical episodes of malaria varies markedly with 
seasonal changes in the intensity of parasite transmission, whereas 
the prevalence of infection (whether symptomatic or not) gen-
erally shows much less seasonal variation [6, 7]. These findings 
suggest that chronic parasitemia in semiimmune individuals is 
often suppressed by the immune response to low levels that do 
not cause symptoms, whereas clinical disease is associated with 
mosquito-mediated acquisition of parasites capable of expressing 
new antigenic types not controlled by preexisting immunity [8]. 
However, recent reports indicate that placental P.  falciparum 
malaria may be an important (partial) exception to this rule [9, 10]. 
Their clinical, parasitological, and histological evidence sug-
gests that placental malaria often follows when already infected 
women become pregnant, rather than when women who are 
already pregnant become infected owing to mosquito bites. This 
scenario is supported by occasional case reports [11].
The PfEMP1-based interpretation of the above findings is 
that placental malaria may be caused by asymptomatic infec-
tions present before conception (in addition to newly acquired 
infections), as the parasites seize the opportunity to escape 
preexisting immunity when the placenta develops, effectuated 
by switching to expression of VAR2CSA-type PfEMP1. To test 
this hypothesis directly, we selected a study area with marked 
seasonal variation in rainfall (and, hence, likely variation in 
transmission intensity; Supplementary Figure 2) and 2 PfEMP1 
antigens, IT4VAR04 (FV2) and HB3VAR06 (FV6). The former 
antigen is a VAR2CSA-type PfEMP1, whereas the latter is a pro-
tein associated with rosetting and severe malaria in children but 
not with placental malaria.
VAR2CSA-specific IgG levels increase during pregnancy, 
but decline again within months of delivery, as maintenance of 
acquired protection against placental malaria appears to rely 
primarily on memory B cells [5]. Thus, only limited systematic 
variation with seasonal fluctuations in transmission intensity 
would be expected, if indeed placental infection often arises 
from preexisting, nonplacental parasitemia switching to expres-
sion of VAR2CSA-type PfEMP1 without the need for acquisi-
tion of new infection. Indeed, we did not detect much seasonal 
variation in plasma levels of VAR2CSA-specific IgG among the 
pregnant women we studied. In contrast, FV6-specific IgG levels 
would be expected to show some seasonal variation, as boost-
ing should generally require new infection. Again, this is what 
we observed. Nevertheless, we also found that FV2- and FV6-
specific IgG levels correlated to some extent. Although this lim-
its the power of our investigative approach, it is not surprising. 
Thus, some of the parasites in a rapidly expanding population 
expressing VAR2CSA-type PfEMP1 during placental malaria 
are likely to switch to other PfEMP1 types, thereby boosting 
any preexisting immunological memory to those variants. 
This was indeed observed in a previous longitudinal study [5]. 
Furthermore, new infections acquired from mosquito bites 
undoubtedly also contribute to placental malaria [10].
Our study has several limitations. The complex rainfall pat-
tern in the study area makes it difficult to analyze in detail the 
causal relationship between temporal variation in transmission 
patterns and antibody levels. This problem is complicated fur-
ther by the many variables other than transmission intensity that 
potentially contribute to the observed variation in antibody lev-
els. All this notwithstanding, our study supports the notion that 
placental malaria often arises from parasites already present at 
the time of conception, rather than from new infection in women 
already pregnant. This mode of developing placental malaria 
has not often been considered in the literature but should not be 
unexpected, as low-grade, asymptomatic parasitemia is common 
among African adults [12]. It might explain, at least partially, the 
negative impact of low parasitemia levels during early pregnancy 
on pregnancy outcome, even before a fully functional placenta 
has developed [13]. Perhaps even more importantly, this etiology 
might also contribute to the modest protective efficacy of insec-
ticide-treated bed nets against placental malaria as compared to 
their efficacy against malaria in children [14, 15].
Supplementary Data
Supplementary materials are available at The Journal of Infectious 
Diseases online. Consisting of data provided by the authors to 
benefit the reader, the posted materials are not copyedited and 
are the sole responsibility of the authors, so questions or com-
ments should be addressed to the corresponding author.
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